In my understanding of business, at the rate they are growing at, they obviously want to continue fuelling this growth. Sure, maintain the 9m (roughly) expenses for the quarter and growth plateaus but we reach break even and start bringing in profit. However, I don’t think that is what these guys are settling for. For a company in hyper growth stage, it would be a backward step to cap sales force, r &d, product and advertising funding. Personally, without sounding smug, I’ve enjoyed that the Australian market has viewed lvt as a ‘cash burner’. It’s meant the price has stayed steady long enough for me to take my position. In my opinion, management are making the right moves to grow this company to great heights for the future.
DYOR
- Forums
- ASX - By Stock
- Ann: $20 million to be raised via institutional placement
In my understanding of business, at the rate they are growing...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.474M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LVT (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online